Без рубрики

On December 9th, Cédric Blanpain was the guest of the broadcast”Les éclaireurs” on RTBF, Belgian french-speaking TV and radio channel.
The recording is freely available via this page. 

On November 14, during the ceremony of granting noble favors, Professor Blanpain was elevated to the rank of baron by the King of the Belgians. He received this prestigious noble favor for his research work against cancer.

Press highlights

La Monarchie belge
Le Soir Mag
La Libre Belgique
L’Avenir
7sur7
VRT

Professor Blanpain was awarded the prize for the best presentation of the year in the field of biology by the Gordon Research Conferences attendees (regardless the conference).
Gordon Research Conferences is an international forum which organizes dozens of conferences in this field every year.

The team led by Prof. Blanpain has been shortlisted with 11 others teams for the last step of the Grand Challenges award.  
The Plasticity-Tx project aims to construct a catalogue of cell states to uncover the mechanisms that drive cancer cell plasticity and reveal new therapeutic approaches against cancer. 
Official announcement
Press release of the Université Libre de Bruxelles (in French)

Pharmacological targeting of netrin-1 inhibits EMT in cancer.
Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate RM, Bellina M, Moers V, Boinet A, Sifrim A, Rama N, Ducarouge B, Van Herck J, Dubois C, Scozzaro S, Lemaire S, Gieskes S, Bonni S, Collin A, Braissand N, Allard J, Zindy E, Decaestecker C, Sotiriou C, Salmon I, Mehlen P, Voet T, Bernet A, Blanpain C.
Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06372-2.
Pubmed  PDF

Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, Delord JP, Lengrand J, Paradisi A, Fattet L, Garin G, Gheit H, Dalban C, Pastushenko I, Neves D, Jelin R, Gadot N, Braissand N, Léon S, Degletagne C, Matias-Guiu X, Devouassoux-Shisheboran M, Mery-Lamarche E, Allard J, Zindy E, Decaestecker C, Salmon I, Perol D, Dolcet X, Ray-Coquard I,Blanpain C*, Bernet A*, Mehlen P* (*last co-authors)
Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06367-z.
Pubmed  PDF

Press highlights
ULB press release
Centre Léon Bérard press release
RTBF
Le Vif
Le Soir (August 2)
Europe1
France info
Femme actuelle
Le Specialiste
Daily Science
Telesambre
News-Medical-Life-Sciences
BX1
Le Soir (August18)
Le Figaro (link to paid version)
Le Progrès (link to paid version)

Interview with Cédric Blanpain and Alexandra Van Keymeulen in FNRS News.
Cancer : l’avenir de la recherche.  FNRS News, 128, juin 2023, p 52-55.
PDF

RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M, Rodriguez-Acebes S, Blondeau J, Parent MA, Zocco M, Song Y, Latil M, Dubois C, Moers M, Impens F, Van Haver D, Rorive S, Allard J, Uemura A, Sotiropoulou PA, Salmon I, Méndez J, Blanpain C.
Nature 2023. https://doi.org/10.1038/s41586-023-05838-7
Pubmed PDF

Press highlights
ULB press release
Le Soir
La Libre
RTBF
Daily Science
Bioworld 
Esprit Libre

Cédric Blanpain is being given the International Society of Stem Cell Research’s Momentum Award.  This is the first time that such a prestigious award is being given to a researcher working in Europe.

Press highlights
ISSCR press release
ULB press release
RTBF
Le Soir
European Commission
Esprit Libre

Prof Blanpain’s editorial in Fokus. Le Vif l’Express supplement, December 2023.
PDF